Wełnicki, M. “Why We Choose Fenofibrate? Fenofibrate in Long-Term Therapy – Larger Packages, Greater Benefits for Patients With Atherogenic Dyslipidemia”. Medycyna Faktow (J EBM), Vol. 18, no. 2(67), June 2025, pp. 290-2, doi:10.24292/01.MF.0225.18.